Pascale Poullin

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

Paul Coppo, Michaël Schwarzinger, M. Buffet et al. · PLoS ONE · 2010 · 415 citations · Full text

Medicine, Hematology, Internal Medicine +9

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy

Éric Mariotte, Élie Azoulay, Lionel Galicier et al. · The Lancet Haematology · 2016 · 312 citations

Medicine, Hematology, Pathology +7

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger et al. · Blood · 2006 · 294 citations · Full text

Medicine, Hematology, Internal Medicine +7

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Antoine Froissart, M. Buffet, Agnès Veyradier et al. · Critical Care Medicine · 2011 · 291 citations

Medicine, Hematology, Immunology +13

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Julie Gay, Lionel Galicier, François Provôt et al. · Blood · 2014 · 188 citations · Full text

Medicine, Hematology, Immunology +6